NASDAQ
Co-Diagnostics, Inc. (CODX) has a price/fcf ratio of -0.23x as of Monday, May 25, 2026. This represents a 104.66% decrease compared to its 12-month average of 4.85x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.